Device Trial Radar · NCT03157297
Micra Atrial Tracking Using a Ventricular Accelerometer Study
Last checked: Nov 19, 2026Latest source record: Oct 26, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
Jul 10, 2017
Primary completion
Nov 24, 2017
Study completion Nov 24, 2017
Sponsor
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
- Sponsor type
- Industry
- First posted
- May 17, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to characterize performance of the MARVEL algorithm downloaded into the MicraTM TPS to provide atrial synchronous ventricular pacing in subjects with AV block. A sub-study will be conducted within the Marvel study, the purpose of this study is to characterize the MARVEL algorithm in patients who were enrolled in the MARVEL study, and to collect and compare the accelerometer signals and AV synchrony at a second point in time.
Conditions
- Atrioventricular Conduction Block
Interventions
MARVEL algorithmDevice
Software download into implanted Micra device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Atrioventricular synchronyTime frame: Initial 24 hour period after patient enrollment
- MARVEL Evolve SubstudyTime frame: Initial 24 hour period after patient enrollment
Locations
13 sites in 9 countries. Site status is shown where the registry gives one.
Baptist Medical Center Jacksonville
Jacksonville, Florida
Baptist Hospital
Miami, Florida
Emory University Hospital
Atlanta, Georgia
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.